Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials


Journal article


Stephanie Sasse, Paul J Bröckelmann, Helen Goergen, Annette Plütschow, Horst Müller, Stefanie Kreissl, Carolin Buerkle, Sven Borchmann, Michael Fuchs, Peter Borchmann, Volker Diehl, Andreas Engert
Journal of Clinical Oncology, vol. 35(18), 2017 Mar 18, pp. 1999-2007

Cite

APA
Sasse, S., Bröckelmann, P. J., Goergen, H., Plütschow, A., Müller, H., Kreissl, S., … Engert, A. (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. Journal of Clinical Oncology, 35(18), 1999–2007.

Chicago/Turabian
Sasse, Stephanie, Paul J Bröckelmann, Helen Goergen, Annette Plütschow, Horst Müller, Stefanie Kreissl, Carolin Buerkle, et al. “Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.” Journal of Clinical Oncology 35, no. 18 (March 18, 2017): 1999–2007.

MLA
Sasse, Stephanie, et al. “Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.” Journal of Clinical Oncology, vol. 35, no. 18, Mar. 2017, pp. 1999–2007.